Cargando…

The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer

Endometrial carcinoma is the most common malignant tumor of the female genital tract in the United States. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins which regulate gene expression. In order to investigate the role of PPARs in endometrial cancer, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Psilopatis, Iason, Vrettou, Kleio, Troungos, Constantinos, Theocharis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252196/
https://www.ncbi.nlm.nih.gov/pubmed/37298140
http://dx.doi.org/10.3390/ijms24119190
_version_ 1785056112249143296
author Psilopatis, Iason
Vrettou, Kleio
Troungos, Constantinos
Theocharis, Stamatios
author_facet Psilopatis, Iason
Vrettou, Kleio
Troungos, Constantinos
Theocharis, Stamatios
author_sort Psilopatis, Iason
collection PubMed
description Endometrial carcinoma is the most common malignant tumor of the female genital tract in the United States. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins which regulate gene expression. In order to investigate the role of PPARs in endometrial cancer, we conducted a literature review using the MEDLINE and LIVIVO databases and were able to identify 27 relevant studies published between 2000 and 2023. The PPARα and PPARβ/δ isoforms seemed to be upregulated, whereas PPARγ levels were reported to be significantly lower in endometrial cancer cells. Interestingly, PPAR agonists were found to represent potent anti-cancer therapeutic alternatives. In conclusion, PPARs seem to play a significant role in endometrial cancer.
format Online
Article
Text
id pubmed-10252196
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102521962023-06-10 The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer Psilopatis, Iason Vrettou, Kleio Troungos, Constantinos Theocharis, Stamatios Int J Mol Sci Review Endometrial carcinoma is the most common malignant tumor of the female genital tract in the United States. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor proteins which regulate gene expression. In order to investigate the role of PPARs in endometrial cancer, we conducted a literature review using the MEDLINE and LIVIVO databases and were able to identify 27 relevant studies published between 2000 and 2023. The PPARα and PPARβ/δ isoforms seemed to be upregulated, whereas PPARγ levels were reported to be significantly lower in endometrial cancer cells. Interestingly, PPAR agonists were found to represent potent anti-cancer therapeutic alternatives. In conclusion, PPARs seem to play a significant role in endometrial cancer. MDPI 2023-05-24 /pmc/articles/PMC10252196/ /pubmed/37298140 http://dx.doi.org/10.3390/ijms24119190 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Psilopatis, Iason
Vrettou, Kleio
Troungos, Constantinos
Theocharis, Stamatios
The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title_full The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title_fullStr The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title_full_unstemmed The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title_short The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
title_sort role of peroxisome proliferator-activated receptors in endometrial cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252196/
https://www.ncbi.nlm.nih.gov/pubmed/37298140
http://dx.doi.org/10.3390/ijms24119190
work_keys_str_mv AT psilopatisiason theroleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT vrettoukleio theroleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT troungosconstantinos theroleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT theocharisstamatios theroleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT psilopatisiason roleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT vrettoukleio roleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT troungosconstantinos roleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer
AT theocharisstamatios roleofperoxisomeproliferatoractivatedreceptorsinendometrialcancer